Exagen Statistics

Share Statistics

Exagen has 22M shares outstanding. The number of shares has increased by 25.73% in one year.

Shares Outstanding	22M
Shares Change (YoY)	25.73%
Shares Change (QoQ)	22.14%
Owned by Institutions (%)	33.61%
Shares Floating	13.55M
Failed to Deliver (FTD) Shares	295
FTD / Avg. Volume	0.1%

Short Selling Information

The latest short interest is 922.6K, so 4.22% of the outstanding shares have been sold short.

Short Interest	922.6K
Short % of Shares Out	4.22%
Short % of Float	5.18%
Short Ratio (days to cover)	4.21

Valuation Ratios

The PE ratio is -4.94 and the forward PE ratio is -24.16. Exagen's PEG ratio is 0.13.

PE Ratio	-4.94
Forward PE	-24.16
PS Ratio	1.34
Forward PS	2.7
PB Ratio	7.82
P/FCF Ratio	-5.41
PEG Ratio	0.13

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Exagen.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.7, with a Debt / Equity ratio of 2.45.

Current Ratio	2.7
Quick Ratio	2.7
Debt / Equity	2.45
Debt / EBITDA	-2.1
Debt / FCF	-1.69
Interest Coverage	-6.1

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$266.22K
Profits Per Employee	$-72.32K
Employee Count	209
Asset Turnover	1.25
Inventory Turnover	n/a

Taxes

Income Tax	12K
Effective Tax Rate	-0.08%

Stock Price Statistics

The stock price has increased by 179.17% in the last 52 weeks. The beta is 1.62, so Exagen's price volatility has been higher than the market average.

Beta	1.62
52-Week Price Change	179.17%
50-Day Moving Average	7.41
200-Day Moving Average	5.04
Relative Strength Index (RSI)	77.85
Average Volume (20 Days)	296,727

Income Statement

In the last 12 months, Exagen had revenue of 55.64M and earned -15.12M in profits. Earnings per share was -0.83.

Revenue	55.64M
Gross Profit	33.11M
Operating Income	-13.64M
Net Income	-15.12M
EBITDA	-11.14M
EBIT	-12.87M
Earnings Per Share (EPS)	-0.83

Full Income Statement

Balance Sheet

The company has 22.04M in cash and 23.36M in debt, giving a net cash position of -1.33M.

Cash & Cash Equivalents	22.04M
Total Debt	23.36M
Net Cash	-1.33M
Retained Earnings	-294.33M
Total Assets	58.76M
Working Capital	40.69M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -13.28M and capital expenditures -515K, giving a free cash flow of -13.79M.

Operating Cash Flow	-13.28M
Capital Expenditures	-515K
Free Cash Flow	-13.79M
FCF Per Share	-0.76

Full Cash Flow Statement

Margins

Gross margin is 59.51%, with operating and profit margins of -24.51% and -27.17%.

Gross Margin	59.51%
Operating Margin	-24.51%
Pretax Margin	-27.14%
Profit Margin	-27.17%
EBITDA Margin	-20.03%
EBIT Margin	-24.51%
FCF Margin	-24.79%

Dividends & Yields

XGN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for XGN is $11.5, which is 22.6% higher than the current price. The consensus rating is "Buy".

Price Target	$11.5
Price Target Difference	22.6%
Analyst Consensus	Buy
Analyst Count	4

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	-2.91
Piotroski F-Score	5

Exagen Inc. (XGN)